C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/07/2004	US6828138 Recombinant sendai virus vector including a gene encoding a chemokine
12/07/2004	US6828137 Methods for producing polypeptides in aspergillus mutant cells
12/07/2004	US6828136 Esterase enzymes, DNA encoding esterase enzymes and vectors and host cells incorporating same
12/07/2004	US6828133 Recombinant vanadium haloperoxidases and their uses
12/07/2004	US6828129 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
12/07/2004	US6828128 β1,3-galactosyltransferase and DNA encoding the same
12/07/2004	US6828127 Amplifying preferential nucleotide sequences in sample; obtain ribonucleic acid sequences, incubate with complimentary sequences and polymerase, amplify nucleotide sequences, recover amplified products
12/07/2004	US6828126 Methods for introducing hydroxyl or epoxide groups into polyketides using OleP
12/07/2004	US6828125 DNA encoding fused di-alpha globins and use thereof
12/07/2004	US6828124 Recombinant DNA vectors for expression of somatotropins
12/07/2004	US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828121 Genetically engineered cells for use in the generatin of heterologous polypeptides
12/07/2004	US6828115 Epoxide hydrolases from streptomyces
12/07/2004	US6828114 Monoclonal antibody against apolipoprotein A-I
12/07/2004	US6828112 Monitoring protein preferential protein activities; obtain cell, transform cell with vector, express vector, monitor cell for reporter molecule expression
12/07/2004	US6828105 Methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a
12/07/2004	US6828100 Method of DNA sequencing
12/07/2004	US6828099 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
12/07/2004	US6828098 Amplification of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences
12/07/2004	US6828095 Modulators of morphogen expression and methods of identifying the same
12/07/2004	US6828094 Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application
12/07/2004	US6828093 Rapid subcloning using site-specific recombination
12/07/2004	US6828092 In vivo assays for modulators of sterol biosynthesis
12/07/2004	US6827938 Compositions and methods for improving kidney function
12/07/2004	US6827935 Method of and compositions for immunization with the pseudomonas V antigen
12/07/2004	US6827925 Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof
12/07/2004	US6827830 Electrophoretic nucleic acid purification method
12/07/2004	CA2158834C Antisense oligos which interfere with mrna cap activity and inhibit translation
12/07/2004	CA1341467C Producing commercially valuable polypeptides with genetically transformed endosperm tissue
12/06/2004	CA2469992A1 Transgenic animal model for glyt1 function
12/02/2004	WO2004104582A1 Method of measuring dna methylation ratio
12/02/2004	WO2004104224A2 Markers for lxr activation
12/02/2004	WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004	WO2004104214A2 Methods and devices for multiplexing amplification reactions
12/02/2004	WO2004104213A2 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
12/02/2004	WO2004104209A1 Process for producing extract for cell-free protein synthesis and cell extract produced thereby
12/02/2004	WO2004104204A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES
12/02/2004	WO2004104203A1 Method of measuring glycolated hemoglobin a1c, enzyme to be used therefor and process for producing the same
12/02/2004	WO2004104202A1 Dna coding for protein having d-lactic acid dehydrogenase activity and use thereof
12/02/2004	WO2004104201A1 Antifreezing protein found in fish
12/02/2004	WO2004104200A1 Method of controlling cell proliferation by using novel function of myeloid leukemia factor mlf1 and utilization of the same
12/02/2004	WO2004104199A2 Modulation of gene expression using dna-dna hybrids
12/02/2004	WO2004104198A1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO
12/02/2004	WO2004104197A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
12/02/2004	WO2004104196A1 Buffer composition
12/02/2004	WO2004104195A1 Insulin-producing cells and method of constructing the same
12/02/2004	WO2004104194A1 Compositions and methods for site-specific recombination and expression
12/02/2004	WO2004104190A2 Methods and compositions for the production of adenoviral vectors
12/02/2004	WO2004104189A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004	WO2004104181A2 Nucleic acid processing methods, kits and devices
12/02/2004	WO2004104180A2 Genes encoding carotenoid biosynthetic enzymes
12/02/2004	WO2004104179A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004	WO2004104174A2 Polyubiquitin rubi3 promoter and 5' regulatory sequences
12/02/2004	WO2004104170A2 Tools for detecting moraxella catarrhalis.
12/02/2004	WO2004104169A2 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
12/02/2004	WO2004104165A2 Ura5 gene and methods for stable genetic integration in yeast
12/02/2004	WO2004104162A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
12/02/2004	WO2004104161A2 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
12/02/2004	WO2004104045A1 Therapeutical use of anti-cd70 antibody for treating or preventing aids
12/02/2004	WO2004104038A1 Control of the intracellular localization of ip3 receptor
12/02/2004	WO2004104037A1 Method for screening inhibitors of the gamma-secretase
12/02/2004	WO2004104035A1 Regulation of growth in plants
12/02/2004	WO2004104033A2 Viruses dependent on inducing agents for viral entry into a host cell
12/02/2004	WO2004104032A2 Methods and compositions related to high-titer pseudotyped retroviruses
12/02/2004	WO2004104026A1 Peptide complex
12/02/2004	WO2004103389A2 Means for preventing and treating cellular death and their biological applications
12/02/2004	WO2004103316A2 Orp9, a novel therapeutic target for increasing hdl levels
12/02/2004	WO2004103275A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants
12/02/2004	WO2004103268A2 Intracellular production of specific rna molecules by splicing
12/02/2004	WO2004103067A2 A transgenic animal model for cancer and stem cells
12/02/2004	WO2004096827A3 Plant retroelements and methods related thereto
12/02/2004	WO2004090132A3 Method for isolating nucleic acids
12/02/2004	WO2004090095A3 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
12/02/2004	WO2004087868A3 Dna polymerase fusions and uses thereof
12/02/2004	WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/02/2004	WO2004080386A3 Optimization of bacterial sucab expression by promoter mutagenesis for efficient l-glutamic acid production
12/02/2004	WO2004078909A8 Identification of antigen epitopes
12/02/2004	WO2004076672A3 Novel dominant selection marker for the transformation of fungi
12/02/2004	WO2004074497A3 Endomannosidases in the modification of glycoproteins in eukaryotes
12/02/2004	WO2004074490A3 Method for transforming blakeslea strains
12/02/2004	WO2004072251A3 Directed genetic modifications of human stem cells
12/02/2004	WO2004069870A3 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
12/02/2004	WO2004067746A8 Ires
12/02/2004	WO2004067563A8 Peptide inhibitors of toxins derived from ll-37
12/02/2004	WO2004066183A3 Microrna
12/02/2004	WO2004065440A3 Cationic graft-copolymer for non-viral gene delivery vector
12/02/2004	WO2004058192A3 Reversible masking of liposomal complexes for targeted delivery
12/02/2004	WO2004050027A3 Materials and methods for treating ocular-related disorders
12/02/2004	WO2004049794A3 Single chain antibodies produced in a transgenic mouse
12/02/2004	WO2004042064A3 Disorders of lipid metabolism
12/02/2004	WO2004035750A3 Methods for accumulating translocated proteins
12/02/2004	WO2004031359A3 Method for regulating expression genes
12/02/2004	WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use
12/02/2004	WO2004013295A3 Plant rna binding protein, encoding nucleic acids, and methods of use
12/02/2004	WO2004012585A3 Electrophysiology assay methods
12/02/2004	WO2004009797A3 Protein modification and maintenance molecules
12/02/2004	WO2004005221A3 Benzoate- and anthranilate-inducible promoters
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003089605A3 Method of creating a library of bacterial clones with varying levels of gene expression

1 ... 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 ... 4023